ESLICARBAZEPINE ACETATE

ESLICARBAZEPINE ACETATE was reported 3321 times

ESLICARBAZEPINE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEW ONSET REFRACTORY STATUS EPILEPTICUS 26 0.2364
1 INSULIN C-PEPTIDE ABNORMAL 2 0.1053
2 DELAYED MYELINATION 2 0.0909
3 AXILLARY LYMPHADENECTOMY 7 0.0897
4 CRANIAL NERVE DECOMPRESSION 1 0.0556
5 FONTANELLE BULGING 6 0.0508
6 CEREBRAL MICROEMBOLISM 1 0.0455
7 SIDEROBLASTIC ANAEMIA 6 0.0429
8 DEVICE STIMULATION ISSUE 1 0.0400
9 EPILEPSY SURGERY 1 0.0400
10 FEBRILE INFECTION-RELATED EPILEPSY SYNDROME 1 0.0323
11 POSTICTAL PSYCHOSIS 5 0.0321
12 ECTOPIC KIDNEY 3 0.0316
13 EPILEPTIC AURA 7 0.0271
14 EPIPHYSEAL FRACTURE 1 0.0250
15 DELUSIONAL DISORDER, EROTOMANIC TYPE 1 0.0238
16 SEIZURE CLUSTER 19 0.0229
17 PULMONARY HAEMORRHAGE NEONATAL 2 0.0217
18 ACANTHOSIS NIGRICANS 4 0.0216
19 CONJOINED TWINS 2 0.0202
20 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 10 0.0187
21 CHANGE IN SEIZURE PRESENTATION 12 0.0185
22 ELECTROENCEPHALOGRAM 1 0.0179
23 POSTURING 9 0.0173
24 INTERMITTENT EXPLOSIVE DISORDER 2 0.0171
25 BRAIN LOBECTOMY 1 0.0169
26 CARDIAC VALVE THICKENING 1 0.0169
27 UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE 2 0.0168
28 SIMPLE PARTIAL SEIZURES 13 0.0161
29 DRUG LEVEL 1 0.0147
30 EXHIBITIONISM 1 0.0139
31 PARTIAL SEIZURES 72 0.0137
32 BRAIN OPERATION 31 0.0136
33 MIXED ANXIETY AND DEPRESSIVE DISORDER 5 0.0135
34 CYTOTOXIC LESIONS OF CORPUS CALLOSUM 2 0.0135
35 CRYOTHERAPY 1 0.0135
36 LENNOX-GASTAUT SYNDROME 3 0.0132
37 ADAMS-STOKES SYNDROME 2 0.0130
38 BRIEF PSYCHOTIC DISORDER, WITH POSTPARTUM ONSET 1 0.0128
39 AURA 23 0.0123
40 DRUG DOSE TITRATION NOT PERFORMED 21 0.0115
41 DELUSION OF REPLACEMENT 1 0.0100
42 VAGAL NERVE STIMULATOR IMPLANTATION 3 0.0098
43 FOCAL DYSCOGNITIVE SEIZURES 11 0.0097
44 DRUG TITRATION ERROR 24 0.0093
45 DREAMY STATE 3 0.0093
46 MULTIPLE-DRUG RESISTANCE 28 0.0090
47 SEIZURE 1014 0.0088
48 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 4 0.0085
49 PETIT MAL EPILEPSY 43 0.0084
50 POSTICTAL PARALYSIS 2 0.0083
51 DEJA VU 2 0.0073
52 BLOOD INSULIN INCREASED 4 0.0072
53 GENERALISED TONIC-CLONIC SEIZURE 118 0.0071
54 ATONIC SEIZURES 6 0.0070
55 LABELLED DRUG-DRUG INTERACTION ISSUE 10 0.0069
56 THERAPEUTIC PRODUCT EFFECT INCREASED 8 0.0069
57 AMNIOTIC FLUID VOLUME INCREASED 1 0.0063
58 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 2 0.0063
59 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 1 0.0062
60 BLOOD CHLORIDE ABNORMAL 1 0.0062
61 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 3 0.0062
62 HIRSUTISM 8 0.0060
63 TONGUE EXFOLIATION 2 0.0057
64 ANTICONVULSANT DRUG LEVEL ABNORMAL 1 0.0057
65 TIME PERCEPTION ALTERED 2 0.0055
66 PITYRIASIS ROSEA 2 0.0054
67 POLYCYSTIC OVARIES 8 0.0052
68 CONVULSIVE THRESHOLD LOWERED 2 0.0051
69 IMPULSE-CONTROL DISORDER 10 0.0049
70 AUTOMATISM 1 0.0046
71 INTELLECTUAL DISABILITY 7 0.0046
72 DAYDREAMING 7 0.0045
73 TONIC CONVULSION 6 0.0042
74 FOETAL EXPOSURE TIMING UNSPECIFIED 3 0.0042
75 NEURAL TUBE DEFECT 3 0.0041
76 CEREBELLAR SYNDROME 9 0.0041
77 BLOOD LUTEINISING HORMONE INCREASED 1 0.0041
78 EAR INJURY 2 0.0040
79 AUTOPHOBIA 1 0.0039
80 DRUG WITHDRAWAL CONVULSIONS 7 0.0039
81 DENTURE WEARER 1 0.0039
82 FACIAL WASTING 1 0.0037
83 SLOW SPEECH 9 0.0037
84 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 32 0.0036
85 COMPLEX PARTIAL SEIZURES 4 0.0036
86 ENAMEL ANOMALY 1 0.0035
87 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
88 CEREBELLAR ATROPHY 3 0.0034
89 EAR TUBE INSERTION 1 0.0034
90 DROP ATTACKS 2 0.0034
91 DEFIANT BEHAVIOUR 1 0.0032
92 WRONG SCHEDULE 3 0.0031
93 COLD-STIMULUS HEADACHE 1 0.0031
94 CONDUCTIVE DEAFNESS 1 0.0031
95 ASOCIAL BEHAVIOUR 1 0.0031
96 LIP INJURY 4 0.0031
97 HYPONATRAEMIA 172 0.0031
98 POSTICTAL STATE 3 0.0029
99 STATUS EPILEPTICUS 32 0.0028
100 PULMONARY VALVE INCOMPETENCE 4 0.0027
101 TRIGEMINAL NEURALGIA 11 0.0027
102 EAR OPERATION 1 0.0027
103 DIZZINESS EXERTIONAL 2 0.0026
104 BLOOD SODIUM DECREASED 49 0.0026
105 WRONG DOSE 6 0.0025
106 WRONG PATIENT RECEIVED PRODUCT 7 0.0024
107 FOOD AVERSION 4 0.0024
108 DEAFNESS BILATERAL 4 0.0024
109 TENSION HEADACHE 10 0.0023
110 HYPERTONIA 13 0.0023
111 ATAXIA 26 0.0022
112 CREATININE RENAL CLEARANCE ABNORMAL 1 0.0022
113 PSYCHOGENIC SEIZURE 2 0.0021
114 ANTICONVULSANT DRUG LEVEL DECREASED 3 0.0021
115 BEHAVIOUR DISORDER 11 0.0020
116 ELECTROLYTE DEPLETION 1 0.0020
117 DEPRESSIVE SYMPTOM 7 0.0020
118 MYOCLONIC EPILEPSY 3 0.0020
119 DROWNING 2 0.0020
120 FEMALE STERILISATION 1 0.0019
121 GASTROSTOMY 3 0.0019
122 PSYCHOMOTOR SKILLS IMPAIRED 5 0.0019
123 BLOOD SODIUM ABNORMAL 2 0.0019
124 COATING IN MOUTH 1 0.0019
125 PULMONARY ARTERIAL PRESSURE INCREASED 3 0.0018
126 CLUMSINESS 5 0.0018
127 COMMUNICATION DISORDER 7 0.0018
128 CLONUS 5 0.0018
129 EPILEPSY 55 0.0018
130 ENCEPHALOMALACIA 1 0.0018
131 CYTOGENETIC ABNORMALITY 2 0.0018
132 SEIZURE LIKE PHENOMENA 3 0.0018
133 ENANTHEMA 1 0.0017
134 HYPOCHLORAEMIA 2 0.0017
135 ENDOTRACHEAL INTUBATION COMPLICATION 1 0.0017
136 BICUSPID AORTIC VALVE 1 0.0017
137 BRADYPHRENIA 11 0.0017
138 DERMATILLOMANIA 1 0.0017
139 OBSESSIVE THOUGHTS 3 0.0017
140 STARING 4 0.0017
141 ALLERGY TO CHEMICALS 2 0.0016
142 DECREASED ACTIVITY 17 0.0016
143 SEDATION COMPLICATION 4 0.0016
144 BLOOD CHLORIDE DECREASED 4 0.0015
145 ENDOMETRITIS 1 0.0015
146 PRESCRIBED UNDERDOSE 30 0.0015
147 HYPERSOMNIA 43 0.0015
148 ANXIETY DISORDER 5 0.0015
149 CHANGE OF BOWEL HABIT 3 0.0015
150 ANGULAR CHEILITIS 1 0.0014
151 DRUG SCREEN FALSE POSITIVE 4 0.0014
152 HYPERREFLEXIA 5 0.0014
153 ELECTRIC SHOCK SENSATION 4 0.0014
154 HYPERAMMONAEMIA 7 0.0014
155 THERAPY INTERRUPTED 100 0.0014
156 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 36 0.0014
157 LANGUAGE DISORDER 3 0.0014
158 DIPLOPIA 36 0.0014
159 AMMONIA INCREASED 7 0.0014
160 AORTIC VALVE SCLEROSIS 1 0.0014
161 BLUNTED AFFECT 1 0.0014
162 EXCESSIVE EYE BLINKING 2 0.0014
163 CARCINOID TUMOUR 1 0.0013
164 PRESCRIBED OVERDOSE 26 0.0013
165 READING DISORDER 3 0.0013
166 ORAL MUCOSAL ERUPTION 2 0.0013
167 MEAN CELL VOLUME DECREASED 2 0.0013
168 TALIPES 4 0.0013
169 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 13 0.0013
170 INAPPROPRIATE AFFECT 2 0.0013
171 HEPATIC CYTOLYSIS 16 0.0013
172 CARTILAGE ATROPHY 1 0.0012
173 FEAR OF FALLING 1 0.0012
174 CEREBRAL DISORDER 9 0.0012
175 NEAR DEATH EXPERIENCE 4 0.0012
176 RESUSCITATION 2 0.0012
177 COVID-19 IMMUNISATION 1 0.0012
178 ATRIOVENTRICULAR BLOCK COMPLETE 8 0.0012
179 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
180 CHOROIDAL NEOVASCULARISATION 1 0.0012
181 UNDERDOSE 85 0.0012
182 ALCOHOL WITHDRAWAL SYNDROME 1 0.0011
183 BLOOD SODIUM INCREASED 3 0.0011
184 INTENTIONAL UNDERDOSE 8 0.0011
185 PUPILLARY REFLEX IMPAIRED 2 0.0011
186 SNORING 4 0.0011
187 SKIN ABRASION 5 0.0011
188 CEREBELLAR ATAXIA 1 0.0010
189 CLEFT PALATE 2 0.0010
190 CROSS SENSITIVITY REACTION 1 0.0010
191 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
192 STRIDOR 3 0.0010
193 DROOLING 7 0.0010
194 HYPOGLYCAEMIC UNCONSCIOUSNESS 2 0.0010
195 CRANIOCEREBRAL INJURY 3 0.0010
196 TONGUE BITING 2 0.0010
197 CONSCIOUSNESS FLUCTUATING 1 0.0010
198 SOMNOLENCE 193 0.0010
199 BONE DEMINERALISATION 1 0.0009
200 ASTERIXIS 1 0.0009
201 STUPOR 3 0.0009
202 OVERWEIGHT 5 0.0009
203 MUSCLE RIGIDITY 11 0.0009
204 DYSPHEMIA 4 0.0009
205 ACCIDENT AT WORK 2 0.0009
206 DANDRUFF 2 0.0009
207 CONGENITAL ANOMALY 7 0.0009
208 AORTIC DILATATION 1 0.0009
209 ESSENTIAL TREMOR 1 0.0009
210 FACIAL SPASM 1 0.0009
211 ANGER 30 0.0009
212 DYSLEXIA 1 0.0009
213 FLAT AFFECT 2 0.0009
214 MYDRIASIS 11 0.0009
215 ORAL SURGERY 2 0.0009
216 ALTERED STATE OF CONSCIOUSNESS 18 0.0008
217 CARDIAC DEATH 1 0.0008
218 FEBRILE CONVULSION 1 0.0008
219 CONCOMITANT DISEASE AGGRAVATED 5 0.0008
220 FEELING DRUNK 6 0.0008
221 BLOOD UREA DECREASED 1 0.0008
222 GASTROINTESTINAL TUBE INSERTION 2 0.0008
223 COORDINATION ABNORMAL 11 0.0008
224 SCREAMING 5 0.0008
225 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
226 IRRITABILITY 47 0.0008
227 INCOHERENT 5 0.0008
228 LUPUS-LIKE SYNDROME 7 0.0008
229 PRODUCT ADMINISTRATION INTERRUPTED 6 0.0008
230 ENCEPHALITIS AUTOIMMUNE 1 0.0008
231 POLYARTHRITIS 4 0.0008
232 WALKING AID USER 5 0.0008
233 FEELING GUILTY 1 0.0008
234 BALANCE DISORDER 65 0.0008
235 BLOOD POTASSIUM ABNORMAL 2 0.0007
236 AGITATION 55 0.0007
237 CARBON DIOXIDE INCREASED 1 0.0007
238 APHASIA 22 0.0007
239 SUICIDAL BEHAVIOUR 3 0.0007
240 CARDIOVERSION 1 0.0007
241 ECHOCARDIOGRAM ABNORMAL 1 0.0007
242 APPENDIX DISORDER 1 0.0007
243 AORTIC VALVE INCOMPETENCE 3 0.0007
244 AUDITORY DISORDER 1 0.0007
245 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 38 0.0007
246 HALLUCINATION, AUDITORY 11 0.0007
247 SEDATION 18 0.0007
248 MEMORY IMPAIRMENT 94 0.0007
249 HEAD DISCOMFORT 12 0.0007
250 SUICIDAL IDEATION 62 0.0007
251 ABORTION SPONTANEOUS 27 0.0007
252 COMA 32 0.0007
253 MYOCLONUS 8 0.0007
254 METABOLIC ENCEPHALOPATHY 2 0.0007
255 DYSARTHRIA 25 0.0007
256 MOOD SWINGS 21 0.0007
257 FOETAL GROWTH RESTRICTION 4 0.0007
258 BRAIN NEOPLASM 6 0.0007
259 AGRANULOCYTOSIS 12 0.0006
260 FAMILY STRESS 2 0.0006
261 COGNITIVE DISORDER 30 0.0006
262 APNOEA 5 0.0006
263 AGGRESSION 32 0.0006
264 SINUS TACHYCARDIA 9 0.0006
265 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
266 PULSE ABSENT 3 0.0006
267 SPEECH DISORDER 33 0.0006
268 TRICUSPID VALVE INCOMPETENCE 5 0.0006
269 RASH MACULO-PAPULAR 14 0.0006
270 DRUG RESISTANCE 16 0.0006
271 CYSTITIS INTERSTITIAL 1 0.0006
272 TREATMENT NONCOMPLIANCE 34 0.0006
273 ANTICONVULSANT DRUG LEVEL INCREASED 1 0.0006
274 AMNESIA 40 0.0006
275 ABNORMAL FAECES 5 0.0006
276 HYPERAESTHESIA 5 0.0006
277 OTITIS MEDIA 2 0.0006
278 HYPERNATRAEMIA 3 0.0006
279 LYME DISEASE 2 0.0006
280 BRAIN INJURY 6 0.0006
281 LYMPHADENOPATHY 21 0.0006
282 EYE MOVEMENT DISORDER 4 0.0006
283 LEFT VENTRICULAR FAILURE 2 0.0006
284 PARANOIA 10 0.0006
285 INCREASED APPETITE 11 0.0006
286 HYPOMAGNESAEMIA 8 0.0006
287 EMOTIONAL POVERTY 1 0.0006
288 HANGOVER 2 0.0006
289 DRUG SCREEN NEGATIVE 1 0.0006
290 FACIAL PAIN 5 0.0006
291 NEUTROPENIC SEPSIS 4 0.0006
292 THERAPEUTIC RESPONSE UNEXPECTED 25 0.0006
293 TIC 3 0.0005
294 CUTANEOUS VASCULITIS 2 0.0005
295 RESTLESSNESS 20 0.0005
296 VENTRICULAR TACHYCARDIA 9 0.0005
297 INTENTIONAL SELF-INJURY 11 0.0005
298 BODY TEMPERATURE ABNORMAL 1 0.0005
299 DISORGANISED SPEECH 1 0.0005
300 STEVENS-JOHNSON SYNDROME 12 0.0005
301 HYPERACUSIS 2 0.0005
302 MENTAL IMPAIRMENT 13 0.0005
303 IMPULSIVE BEHAVIOUR 2 0.0005
304 BLOOD IRON INCREASED 1 0.0005
305 ABNORMAL BEHAVIOUR 21 0.0005
306 FACE INJURY 2 0.0005
307 ROAD TRAFFIC ACCIDENT 22 0.0005
308 NEUROLOGICAL SYMPTOM 3 0.0005
309 HALLUCINATION, VISUAL 11 0.0005
310 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
311 PANIC DISORDER 2 0.0005
312 DELUSION 8 0.0005
313 EOSINOPHILIA 9 0.0005
314 URINE ODOUR ABNORMAL 3 0.0005
315 COLOSTOMY 1 0.0005
316 AFFECTIVE DISORDER 4 0.0005
317 PSYCHOTIC DISORDER 15 0.0005
318 THERAPY CESSATION 26 0.0005
319 ENURESIS 2 0.0005
320 EAR HAEMORRHAGE 1 0.0005
321 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 89 0.0005
322 TENSION 3 0.0005
323 DERMATITIS PSORIASIFORM 1 0.0005
324 THINKING ABNORMAL 9 0.0005
325 MENTAL DISORDER 21 0.0005
326 PRE-EXISTING CONDITION IMPROVED 3 0.0005
327 PETECHIAE 5 0.0005
328 DRUG INTERACTION 76 0.0005
329 SELF-INJURIOUS IDEATION 2 0.0005
330 MOOD ALTERED 13 0.0005
331 DILATATION VENTRICULAR 1 0.0005
332 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
333 DEVICE CONNECTION ISSUE 1 0.0005
334 EYE CONTUSION 1 0.0005
335 BUNDLE BRANCH BLOCK LEFT 2 0.0005
336 TONGUE DISCOMFORT 2 0.0005
337 FACIAL PARALYSIS 4 0.0005
338 CHOLESTASIS 9 0.0005
339 ANAEMIA MACROCYTIC 1 0.0005
340 VITAMIN D DECREASED 4 0.0005
341 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
342 DISTURBANCE IN ATTENTION 25 0.0005
343 DIZZINESS 231 0.0005
344 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
345 CHAPPED LIPS 2 0.0005
346 BIPOLAR I DISORDER 1 0.0005
347 DYSGRAPHIA 3 0.0005
348 CLOSTRIDIUM TEST POSITIVE 1 0.0005
349 SLEEP DISORDER 32 0.0005
350 CHOLESTATIC LIVER INJURY 1 0.0004
351 CALCINOSIS 1 0.0004
352 BRAIN FOG 7 0.0004
353 FEAR 12 0.0004
354 MENINGITIS ASEPTIC 2 0.0004
355 DYSSTASIA 13 0.0004
356 HEAD INJURY 14 0.0004
357 MITRAL VALVE INCOMPETENCE 5 0.0004
358 CRYING 16 0.0004
359 LETHARGY 25 0.0004
360 MUSCLE TWITCHING 10 0.0004
361 HUNGER 6 0.0004
362 ERYTHEMA MULTIFORME 4 0.0004
363 UNRESPONSIVE TO STIMULI 11 0.0004
364 DISTURBANCE IN SOCIAL BEHAVIOUR 1 0.0004
365 PRODUCT SUPPLY ISSUE 3 0.0004
366 ACCIDENT 5 0.0004
367 PANIC REACTION 3 0.0004
368 RASH VESICULAR 2 0.0004
369 BRONCHITIS CHRONIC 1 0.0004
370 ORAL DISORDER 3 0.0004
371 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
372 CARTILAGE INJURY 1 0.0004
373 LIGAMENT SPRAIN 4 0.0004
374 DEPRESSED LEVEL OF CONSCIOUSNESS 16 0.0004
375 CONFUSIONAL STATE 65 0.0004
376 ANEURYSM 2 0.0004
377 UPPER LIMB FRACTURE 8 0.0004
378 HYPOTONIA 4 0.0004
379 SALIVARY HYPERSECRETION 4 0.0004
380 DERMATITIS EXFOLIATIVE 2 0.0004
381 CHROMATURIA 9 0.0004
382 DERMATITIS ALLERGIC 5 0.0004
383 PRODUCT ADMINISTRATION ERROR 8 0.0004
384 ENDODONTIC PROCEDURE 1 0.0004
385 VISION BLURRED 54 0.0004
386 FEELING ABNORMAL 94 0.0004
387 SLUGGISHNESS 4 0.0004
388 ANGLE CLOSURE GLAUCOMA 1 0.0004
389 PHARYNGEAL OEDEMA 6 0.0004
390 INITIAL INSOMNIA 4 0.0004
391 MIGRAINE 37 0.0004
392 PRODUCT USE IN UNAPPROVED INDICATION 96 0.0004
393 WEIGHT FLUCTUATION 4 0.0004
394 NYSTAGMUS 2 0.0004
395 MIDDLE INSOMNIA 7 0.0004
396 POOR QUALITY SLEEP 8 0.0004
397 FRUSTRATION TOLERANCE DECREASED 3 0.0004
398 OFF LABEL USE 324 0.0004
399 HICCUPS 3 0.0004
400 AUTISM SPECTRUM DISORDER 2 0.0004
401 CHOKING SENSATION 2 0.0004
402 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
403 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
404 NECROSIS 2 0.0004
405 CHOKING 7 0.0004
406 ENDOTRACHEAL INTUBATION 1 0.0004
407 ACUTE PULMONARY OEDEMA 2 0.0004
408 DRUG TOLERANCE DECREASED 1 0.0004
409 PANCREATITIS ACUTE 8 0.0004
410 TREMOR 59 0.0004
411 PREMATURE LABOUR 2 0.0004
412 CHOLECYSTITIS ACUTE 2 0.0004
413 PRODUCT DOSE OMISSION 23 0.0004
414 FALL 117 0.0004
415 BLOOD MAGNESIUM DECREASED 3 0.0003
416 RASH GENERALISED 9 0.0003
417 FIBULA FRACTURE 1 0.0003
418 SKIN SWELLING 3 0.0003
419 COMA SCALE ABNORMAL 1 0.0003
420 GAIT DISTURBANCE 66 0.0003
421 METABOLIC DISORDER 2 0.0003
422 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
423 THIRST 6 0.0003
424 CENTRAL VENOUS CATHETERISATION 1 0.0003
425 EYE INJURY 1 0.0003
426 GAIT INABILITY 11 0.0003
427 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
428 DYSAESTHESIA 1 0.0003
429 MATERNAL EXPOSURE DURING PREGNANCY 29 0.0003
430 ECTOPIC PREGNANCY 1 0.0003
431 DIASTOLIC DYSFUNCTION 1 0.0003
432 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
433 LOSS OF CONSCIOUSNESS 41 0.0003
434 DEPRESSION 72 0.0003
435 DRUG EFFECT INCREASED 1 0.0003
436 SUICIDE ATTEMPT 19 0.0003
437 SEROTONIN SYNDROME 6 0.0003
438 BLOOD POTASSIUM INCREASED 5 0.0003
439 PARKINSONISM 3 0.0003
440 CONDITION AGGRAVATED 93 0.0003
441 COELIAC DISEASE 3 0.0003
442 NEPHROLITHIASIS 14 0.0003
443 SOMNAMBULISM 2 0.0003
444 APPETITE DISORDER 2 0.0003
445 LIP SWELLING 10 0.0003
446 POST-TRAUMATIC STRESS DISORDER 2 0.0003
447 TOXIC SKIN ERUPTION 3 0.0003
448 INTENTIONAL OVERDOSE 19 0.0003
449 WRONG PRODUCT ADMINISTERED 2 0.0003
450 DYSKINESIA 12 0.0003
451 DRUG LEVEL DECREASED 3 0.0003
452 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
453 HALLUCINATION 22 0.0003
454 DEPRESSION SUICIDAL 1 0.0003
455 DERMATITIS EXFOLIATIVE GENERALISED 1 0.0003
456 CAROTID ARTERY STENOSIS 1 0.0003
457 EMBOLIC STROKE 1 0.0003
458 JOINT DISLOCATION 3 0.0003
459 SUDDEN DEATH 3 0.0003
460 JOINT INJURY 6 0.0003
461 BODY HEIGHT DECREASED 3 0.0003
462 PARALYSIS 4 0.0003
463 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
464 VERTIGO 17 0.0003
465 FACIAL BONES FRACTURE 1 0.0003
466 VISUAL FIELD DEFECT 2 0.0003
467 SKIN LACERATION 3 0.0003
468 BACK INJURY 3 0.0003
469 FAECES SOFT 2 0.0003
470 RASH PUSTULAR 2 0.0003
471 APATHY 4 0.0003
472 ANXIETY 78 0.0003
473 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
474 FOOD INTOLERANCE 1 0.0003
475 SURGERY 16 0.0003
476 PSYCHIATRIC SYMPTOM 2 0.0003
477 AMYLASE INCREASED 1 0.0003
478 VISUAL ACUITY REDUCED 9 0.0003
479 FOETAL EXPOSURE DURING PREGNANCY 22 0.0003
480 HYPERTENSIVE CRISIS 3 0.0003
481 DRUG INTOLERANCE 26 0.0003
482 NERVOUSNESS 14 0.0003
483 WEIGHT INCREASED 60 0.0003
484 SNEEZING 6 0.0003
485 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 2 0.0003
486 DEPRESSED MOOD 14 0.0003
487 AUTOIMMUNE THYROIDITIS 1 0.0003
488 CHEMOTHERAPY 1 0.0003
489 PRODUCT AVAILABILITY ISSUE 6 0.0003
490 DERMATITIS CONTACT 3 0.0003
491 GLAUCOMA 5 0.0003
492 THYROID DISORDER 4 0.0003
493 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
494 CONCUSSION 2 0.0003
495 EPIGASTRIC DISCOMFORT 1 0.0003
496 HYPOXIA 9 0.0003
497 ABNORMAL DREAMS 7 0.0003
498 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
499 FURUNCLE 2 0.0003
500 BLOOD PRESSURE ABNORMAL 5 0.0003
501 CEREBRAL ATROPHY 1 0.0003
502 WRIST FRACTURE 3 0.0003
503 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
504 SENSORY DISTURBANCE 4 0.0002
505 SENSORY LOSS 2 0.0002
506 HYPERGLYCAEMIA 9 0.0002
507 CYTOPENIA 3 0.0002
508 POLYURIA 2 0.0002
509 INSOMNIA 65 0.0002
510 DEMYELINATION 1 0.0002
511 SMALL INTESTINAL OBSTRUCTION 3 0.0002
512 DYSPHAGIA 23 0.0002
513 ACUTE CORONARY SYNDROME 2 0.0002
514 ILEUS 3 0.0002
515 TINNITUS 11 0.0002
516 PRODUCT DOSE OMISSION ISSUE 70 0.0002
517 SENSATION OF FOREIGN BODY 2 0.0002
518 TACHYCARDIA 21 0.0002
519 HEMIPARESIS 4 0.0002
520 VISUAL IMPAIRMENT 29 0.0002
521 ERECTILE DYSFUNCTION 6 0.0002
522 PRODUCT CONTAINER ISSUE 2 0.0002
523 LIVER FUNCTION TEST INCREASED 5 0.0002
524 DRUG INEFFECTIVE 306 0.0002
525 OVERDOSE 50 0.0002
526 SWELLING FACE 15 0.0002
527 ORTHOSTATIC HYPOTENSION 4 0.0002
528 DRUG ADMINISTRATION ERROR 7 0.0002
529 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 16 0.0002
530 RASH 98 0.0002
531 SWOLLEN TONGUE 7 0.0002
532 HEADACHE 139 0.0002
533 PRODUCT TASTE ABNORMAL 3 0.0002
534 LIMB INJURY 6 0.0002
535 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
536 ABDOMINAL HERNIA 1 0.0002
537 EXOSTOSIS 2 0.0002
538 EAR DISORDER 1 0.0002
539 MOVEMENT DISORDER 7 0.0002
540 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
541 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
542 ORAL DISCOMFORT 3 0.0002
543 PERSONALITY CHANGE 2 0.0002
544 DEMENTIA 6 0.0002
545 MASS 3 0.0002
546 ILLNESS 22 0.0002
547 LACERATION 2 0.0002
548 SEASONAL ALLERGY 3 0.0002
549 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
550 COLITIS MICROSCOPIC 1 0.0002
551 CARDIAC TAMPONADE 1 0.0002
552 ENDOMETRIOSIS 1 0.0002
553 HYPOACUSIS 9 0.0002
554 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
555 PARAESTHESIA ORAL 3 0.0002
556 AFFECT LABILITY 2 0.0002
557 EAR PAIN 4 0.0002
558 PHARYNGEAL SWELLING 2 0.0002
559 HEPATOMEGALY 2 0.0002
560 THERAPY CHANGE 2 0.0002
561 FATIGUE 158 0.0002
562 URINARY INCONTINENCE 6 0.0002
563 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
564 FLUID INTAKE REDUCED 1 0.0002
565 PREGNANCY 4 0.0002
566 SPINAL FRACTURE 4 0.0002
567 HYPOAESTHESIA ORAL 3 0.0002
568 DYSPHORIA 1 0.0002
569 CONTUSION 19 0.0002
570 DYSLIPIDAEMIA 1 0.0002
571 MOTOR DYSFUNCTION 2 0.0002
572 HEPATITIS 5 0.0002
573 EUPHORIC MOOD 2 0.0002
574 FEMORAL NECK FRACTURE 1 0.0002
575 ENDOCARDITIS 1 0.0002
576 EAR DISCOMFORT 2 0.0002
577 EMOTIONAL DISORDER 6 0.0002
578 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
579 TEMPERATURE INTOLERANCE 2 0.0002
580 ANKLE FRACTURE 3 0.0002
581 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
582 MUSCULAR WEAKNESS 22 0.0002
583 WEIGHT DECREASED 54 0.0002
584 EXPOSURE DURING PREGNANCY 12 0.0002
585 APLASTIC ANAEMIA 1 0.0002
586 CYANOSIS 3 0.0002
587 WITHDRAWAL SYNDROME 8 0.0002
588 GASTRITIS 5 0.0002
589 SYNCOPE 19 0.0002
590 BLOOD LACTIC ACID INCREASED 1 0.0002
591 INCONTINENCE 2 0.0002
592 RETCHING 4 0.0002
593 ANAL ABSCESS 1 0.0002
594 BRUXISM 1 0.0002
595 THROAT TIGHTNESS 5 0.0002
596 BIPOLAR DISORDER 2 0.0002
597 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
598 ASPIRATION 2 0.0002
599 FAECALOMA 1 0.0002
600 ASTHENOPIA 1 0.0002
601 GASTROINTESTINAL PAIN 2 0.0002
602 DECREASED APPETITE 42 0.0002
603 DENTAL CARIES 2 0.0002
604 NERVE INJURY 2 0.0002
605 ORAL PAIN 4 0.0002
606 RASH PAPULAR 4 0.0002
607 INTESTINAL PERFORATION 2 0.0002
608 BLOOD CALCIUM DECREASED 2 0.0002
609 PRODUCT USE ISSUE 33 0.0002
610 CHOLECYSTECTOMY 2 0.0002
611 MYOCARDITIS 2 0.0002
612 EXERCISE TOLERANCE DECREASED 1 0.0002
613 ELECTROLYTE IMBALANCE 2 0.0002
614 EYELID OEDEMA 2 0.0002
615 LOCAL SWELLING 3 0.0002
616 DECREASED INTEREST 1 0.0002
617 ENERGY INCREASED 1 0.0002
618 BRADYKINESIA 1 0.0002
619 DRUG ERUPTION 3 0.0002
620 BLOOD IRON DECREASED 2 0.0002
621 PRODUCT PRESCRIBING ERROR 4 0.0002
622 HYPERLIPIDAEMIA 2 0.0002
623 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 8 0.0002
624 HEPATITIS C 2 0.0002
625 FIBROMYALGIA 4 0.0002
626 DERMATITIS ACNEIFORM 1 0.0002
627 RESPIRATORY DEPRESSION 2 0.0002
628 ENCEPHALOPATHY 4 0.0002
629 BLOOD GLUCOSE ABNORMAL 3 0.0002
630 VOMITING 76 0.0002
631 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
632 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
633 PHOTOPHOBIA 3 0.0002
634 BLEPHAROSPASM 1 0.0002
635 BRAIN OEDEMA 2 0.0002
636 ANGIOEDEMA 7 0.0002
637 INTRAOCULAR PRESSURE INCREASED 2 0.0002
638 ERUCTATION 3 0.0002
639 MALAISE 68 0.0002
640 ABDOMINAL DISCOMFORT 26 0.0002
641 SKIN FISSURES 3 0.0002
642 PLATELET COUNT INCREASED 2 0.0002
643 DYSPEPSIA 15 0.0002
644 DISABILITY 3 0.0002
645 SINUS DISORDER 3 0.0002
646 HYPERTENSION 32 0.0002
647 BRADYCARDIA 8 0.0002
648 ADVERSE REACTION 2 0.0002
649 URINARY RETENTION 5 0.0001
650 BREAST MASS 1 0.0001
651 SINUS CONGESTION 2 0.0001
652 FEEDING DISORDER 3 0.0001
653 ASTHENIA 55 0.0001
654 RIB FRACTURE 3 0.0001
655 SKIN LESION 4 0.0001
656 CARDIAC ARREST 12 0.0001
657 GASTROINTESTINAL DISORDER 13 0.0001
658 CHILLS 17 0.0001
659 ENCEPHALITIS 1 0.0001
660 NIGHTMARE 5 0.0001
661 MENTAL STATUS CHANGES 4 0.0001
662 POLLAKIURIA 6 0.0001
663 APHONIA 2 0.0001
664 EXTRASYSTOLES 1 0.0001
665 RASH MACULAR 5 0.0001
666 HYPOAESTHESIA 21 0.0001
667 BRONCHOSPASM 2 0.0001
668 IRRITABLE BOWEL SYNDROME 3 0.0001
669 DRUG DOSE OMISSION 23 0.0001
670 HYPOKINESIA 2 0.0001
671 PANIC ATTACK 5 0.0001
672 ACCIDENTAL OVERDOSE 5 0.0001
673 PALPITATIONS 16 0.0001
674 PERIPHERAL SWELLING 21 0.0001
675 DYSURIA 5 0.0001
676 BLINDNESS TRANSIENT 1 0.0001
677 PULMONARY MASS 2 0.0001
678 NAUSEA 106 0.0001
679 ECZEMA 7 0.0001
680 MUSCULOSKELETAL PAIN 7 0.0001
681 ADVERSE DRUG REACTION 12 0.0001
682 HEPATIC FAILURE 4 0.0001
683 LACRIMATION INCREASED 4 0.0001
684 INSURANCE ISSUE 2 0.0001
685 BOWEL MOVEMENT IRREGULARITY 1 0.0001
686 DISSOCIATION 1 0.0001
687 HYPOKALAEMIA 6 0.0001
688 DEVICE RELATED INFECTION 2 0.0001
689 OROPHARYNGEAL PAIN 12 0.0001
690 MUSCULOSKELETAL CHEST PAIN 2 0.0001
691 URINARY TRACT INFECTION 22 0.0001
692 APHTHOUS ULCER 1 0.0001
693 NERVOUS SYSTEM DISORDER 4 0.0001
694 DRUG SCREEN POSITIVE 1 0.0001
695 DISORIENTATION 5 0.0001
696 INTENTIONAL PRODUCT MISUSE 11 0.0001
697 PREMATURE DELIVERY 2 0.0001
698 MUSCLE TIGHTNESS 2 0.0001
699 EXTRA DOSE ADMINISTERED 5 0.0001
700 PRESYNCOPE 3 0.0001
701 NEURALGIA 3 0.0001
702 DECUBITUS ULCER 1 0.0001
703 BLINDNESS 5 0.0001
704 ASPHYXIA 1 0.0001
705 PRURITUS 47 0.0001
706 BRONCHITIS 9 0.0001
707 MANIA 2 0.0001
708 ABASIA 3 0.0001
709 PHOTOSENSITIVITY REACTION 2 0.0001
710 PNEUMONIA ASPIRATION 3 0.0001
711 COAGULOPATHY 2 0.0001
712 ATRIAL SEPTAL DEFECT 1 0.0001
713 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
714 ABDOMINAL PAIN LOWER 3 0.0001
715 FACE OEDEMA 2 0.0001
716 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
717 CEREBROVASCULAR ACCIDENT 20 0.0001
718 SWELLING 11 0.0001
719 HOSPITALISATION 18 0.0001
720 HYPERHIDROSIS 15 0.0001
721 CARDIAC OPERATION 1 0.0001
722 HAEMATOMA 3 0.0001
723 CARDIAC MURMUR 1 0.0001
724 STOMATITIS 7 0.0001
725 AMENORRHOEA 2 0.0001
726 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
727 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
728 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
729 MENSTRUATION IRREGULAR 3 0.0001
730 CEREBRAL HAEMORRHAGE 4 0.0001
731 BLOOD PRESSURE INCREASED 17 0.0001
732 ANAL INCONTINENCE 1 0.0001
733 DEVELOPMENTAL DELAY 1 0.0001
734 GASTROENTERITIS VIRAL 2 0.0001
735 END STAGE RENAL DISEASE 2 0.0001
736 FEELING COLD 3 0.0001
737 HAEMOPTYSIS 3 0.0001
738 EYE SWELLING 4 0.0001
739 NECK PAIN 6 0.0001
740 BLOOD CHOLESTEROL INCREASED 5 0.0001
741 BLOOD CREATININE INCREASED 7 0.0001
742 BACTERIAL INFECTION 2 0.0001
743 OXYGEN SATURATION DECREASED 6 0.0001
744 ARTERIOSCLEROSIS 1 0.0001
745 ABORTION INDUCED 1 0.0001
746 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
747 FRACTURE 2 0.0001
748 FOOT FRACTURE 2 0.0001
749 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
750 EYE INFLAMMATION 1 0.0001
751 PRODUCT SUBSTITUTION ISSUE 6 0.0001
752 LOWER LIMB FRACTURE 2 0.0001
753 DRUG PRESCRIBING ERROR 2 0.0001
754 DIZZINESS POSTURAL 1 0.0001
755 MUSCULOSKELETAL STIFFNESS 9 0.0001
756 AUTOIMMUNE DISORDER 1 0.0001
757 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
758 PARAESTHESIA 16 0.0001
759 LABORATORY TEST ABNORMAL 3 0.0001
760 CONSTIPATION 22 0.0001
761 HAEMATOCRIT DECREASED 2 0.0001
762 RESPIRATORY DISORDER 3 0.0001
763 INJURY 7 0.0001
764 DRY THROAT 1 0.0001
765 HYPERSENSITIVITY 18 0.0001
766 LIMB DISCOMFORT 3 0.0001
767 TOOTH LOSS 2 0.0001
768 EYE DISCHARGE 1 0.0001
769 ABDOMINAL DISTENSION 10 0.0001
770 CARDIO-RESPIRATORY ARREST 4 0.0001
771 URTICARIA 16 0.0001
772 MOUTH ULCERATION 2 0.0001
773 PANCREATITIS 5 0.0001
774 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
775 ASPARTATE AMINOTRANSFERASE INCREASED 5 0.0001
776 HYPOTHYROIDISM 3 0.0001
777 EATING DISORDER 2 0.0001
778 METABOLIC ACIDOSIS 3 0.0001
779 IMPAIRED WORK ABILITY 2 0.0001
780 NIGHT SWEATS 3 0.0001
781 DRUG EFFECT DECREASED 5 0.0001
782 RASH PRURITIC 5 0.0001
783 PRODUCT PRESCRIBING ISSUE 2 0.0001
784 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
785 DIARRHOEA 59 0.0001
786 EYE DISORDER 3 0.0001
787 EXPIRED PRODUCT ADMINISTERED 3 0.0001
788 OEDEMA PERIPHERAL 11 0.0001
789 VIRAL INFECTION 3 0.0001
790 TRANSAMINASES INCREASED 2 0.0001
791 SKIN DISORDER 3 0.0001
792 TOOTH DISORDER 2 0.0001
793 THROMBOCYTOPENIA 10 0.0001
794 GLOSSODYNIA 2 0.0001
795 THROAT IRRITATION 4 0.0001
796 COUGH 25 0.0001
797 BLISTER 5 0.0001
798 EYE INFECTION 1 0.0001
799 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
800 SKIN DISCOLOURATION 4 0.0001
801 PERICARDIAL EFFUSION 2 0.0001
802 DELIRIUM 3 0.0001
803 BURNING SENSATION 6 0.0001
804 COVID-19 15 0.0001
805 NASAL CONGESTION 5 0.0001
806 COVID-19 PNEUMONIA 1 0.0001
807 BACTERAEMIA 1 0.0001
808 CHOLECYSTITIS 1 0.0001
809 MULTIPLE SCLEROSIS 4 0.0001
810 BLOOD GLUCOSE DECREASED 4 0.0001
811 TOXICITY TO VARIOUS AGENTS 14 0.0001
812 LOCALISED INFECTION 2 0.0001
813 ABDOMINAL PAIN UPPER 17 0.0001
814 HYPOGLYCAEMIA 4 0.0001
815 ADRENAL INSUFFICIENCY 1 0.0001
816 MUSCLE SPASMS 15 0.0001
817 ALOPECIA 16 0.0001
818 INFLUENZA 9 0.0001
819 SEPSIS 9 0.0001
820 CYST 1 0.0001
821 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
822 PNEUMONIA 26 0.0001
823 LEUKOPENIA 4 0.0001
824 INTESTINAL OBSTRUCTION 3 0.0001
825 DIABETES MELLITUS 6 0.0001
826 ERYTHEMA 16 0.0001
827 DYSPNOEA 44 0.0001
828 ABDOMINAL PAIN 18 0.0001
829 RHINORRHOEA 5 0.0001
830 RESPIRATORY TRACT INFECTION 2 0.0001
831 BLOOD PRESSURE DECREASED 5 0.0001
832 EAR INFECTION 2 0.0001
833 DEHYDRATION 10 0.0001
834 EYE HAEMORRHAGE 1 0.0001
835 DRY SKIN 10 0.0001
836 CARDIAC DISORDER 7 0.0001
837 THROMBOSIS 6 0.0001
838 PAIN OF SKIN 2 0.0001
839 PNEUMONITIS 2 0.0001
840 AKATHISIA 1 0.0001
841 ACUTE HEPATIC FAILURE 1 0.0001
842 OSTEOPOROSIS 3 0.0001
843 CORONARY ARTERY OCCLUSION 1 0.0001
844 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
845 RESPIRATORY DISTRESS 2 0.0001
846 MEDICATION ERROR 4 0.0001
847 WOUND 2 0.0001
848 RENAL IMPAIRMENT 6 0.0001
849 BLOOD TEST ABNORMAL 1 0.0001
850 DEVICE OCCLUSION 1 0.0001
851 BLINDNESS UNILATERAL 1 0.0001
852 EYE PAIN 4 0.0001
853 TARDIVE DYSKINESIA 2 0.0001
854 MYALGIA 12 0.0001
855 FLATULENCE 4 0.0001
856 RED BLOOD CELL COUNT DECREASED 2 0.0001
857 CONVULSION 4 0.0001
858 HYPOTENSION 14 0.0001
859 HERPES ZOSTER 4 0.0001
860 MOBILITY DECREASED 5 0.0001
861 EYE IRRITATION 4 0.0001
862 ANOSMIA 1 0.0001
863 SEPTIC SHOCK 3 0.0001
864 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
865 LIVER FUNCTION TEST ABNORMAL 2 0.0001
866 SINUSITIS 7 0.0001
867 ANAEMIA 13 0.0001
868 WHEEZING 4 0.0001
869 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
870 EPISTAXIS 5 0.0001
871 BLOOD POTASSIUM DECREASED 2 0.0001
872 PREMATURE BABY 2 0.0001
873 HOT FLUSH 5 0.0001
874 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
875 BLOOD COUNT ABNORMAL 1 0.0001
876 ACNE 5 0.0001
877 FEELING HOT 4 0.0001
878 GYNAECOMASTIA 2 0.0001
879 EJECTION FRACTION DECREASED 1 0.0001
880 RASH ERYTHEMATOUS 3 0.0001
881 CARDIAC FAILURE 5 0.0001
882 BACK DISORDER 1 0.0001
883 INCORRECT DOSE ADMINISTERED 14 0.0001
884 NO ADVERSE EVENT 11 0.0001
885 PYREXIA 21 0.0001
886 STAPHYLOCOCCAL INFECTION 2 0.0001
887 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
888 DRY EYE 3 0.0001
889 FUNGAL INFECTION 2 0.0001
890 NEOPLASM MALIGNANT 4 0.0001
891 BLOOD UREA INCREASED 1 0.0001
892 NASOPHARYNGITIS 11 0.0001
893 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
894 HEPATIC ENZYME INCREASED 4 0.0001
895 JOINT SWELLING 7 0.0001
896 EMOTIONAL DISTRESS 7 0.0001
897 PAIN IN EXTREMITY 17 0.0001
898 PRODUCT STORAGE ERROR 5 0.0001
899 COLD SWEAT 1 0.0001
900 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
901 DRUG EFFECT INCOMPLETE 2 0.0001
902 C-REACTIVE PROTEIN INCREASED 2 0.0001
903 ANAPHYLACTIC REACTION 3 0.0001
904 ADVERSE EVENT 5 0.0001
905 CHEST PAIN 10 0.0001
906 DYSGEUSIA 4 0.0001
907 DEATH 46 0.0001
908 UNEVALUABLE EVENT 4 0.0001
909 FEELING JITTERY 1 0.0001
910 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
911 NEUTROPENIA 7 0.0001
912 DYSPHONIA 3 0.0001
913 HEART RATE INCREASED 5 0.0001
914 PAIN 31 0.0001
915 THERAPEUTIC RESPONSE DECREASED 3 0.0000
916 DRY MOUTH 4 0.0000
917 BONE MARROW FAILURE 1 0.0000
918 TREATMENT FAILURE 4 0.0000
919 RHABDOMYOLYSIS 2 0.0000
920 BLOOD GLUCOSE INCREASED 9 0.0000
921 DERMATITIS 1 0.0000
922 OSTEOARTHRITIS 2 0.0000
923 PLATELET COUNT DECREASED 5 0.0000
924 FAECES DISCOLOURED 1 0.0000
925 DEVICE DISLOCATION 2 0.0000
926 THERAPY NON-RESPONDER 2 0.0000
927 SKIN IRRITATION 2 0.0000
928 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
929 GENERAL PHYSICAL HEALTH DETERIORATION 5 0.0000
930 RENAL DISORDER 2 0.0000
931 ARRHYTHMIA 2 0.0000
932 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
933 PULMONARY EMBOLISM 4 0.0000
934 BLOOD PRESSURE FLUCTUATION 1 0.0000
935 INFECTION 6 0.0000
936 RESPIRATORY FAILURE 3 0.0000
937 ATRIAL FIBRILLATION 4 0.0000
938 CEREBRAL INFARCTION 1 0.0000
939 LUNG DISORDER 2 0.0000
940 AGEUSIA 1 0.0000
941 CHEST DISCOMFORT 4 0.0000
942 HAEMOGLOBIN DECREASED 4 0.0000
943 ANAPHYLACTIC SHOCK 1 0.0000
944 BACK PAIN 9 0.0000
945 ARTHRALGIA 16 0.0000
946 HAEMORRHAGE 4 0.0000
947 ARTHRITIS 3 0.0000
948 PROSTATE CANCER 3 0.0000
949 BLOOD BILIRUBIN INCREASED 1 0.0000
950 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
951 DIVERTICULITIS 1 0.0000
952 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
953 BONE PAIN 2 0.0000
954 CATARACT 2 0.0000
955 PLEURAL EFFUSION 2 0.0000
956 DISCOMFORT 2 0.0000
957 ACUTE KIDNEY INJURY 5 0.0000
958 DRUG-INDUCED LIVER INJURY 1 0.0000
959 NEUROPATHY PERIPHERAL 3 0.0000
960 CYSTITIS 1 0.0000
961 EYE PRURITUS 1 0.0000
962 FLUSHING 3 0.0000
963 PRODUCT QUALITY ISSUE 4 0.0000
964 SKIN BURNING SENSATION 2 0.0000
965 DYSPNOEA EXERTIONAL 1 0.0000
966 ASTHMA 3 0.0000
967 CARDIAC FAILURE CONGESTIVE 2 0.0000
968 INFLUENZA LIKE ILLNESS 2 0.0000
969 COMPLETED SUICIDE 2 0.0000
970 SKIN EXFOLIATION 2 0.0000
971 CELLULITIS 1 0.0000
972 FLUID RETENTION 1 0.0000
973 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
974 DERMATITIS ATOPIC 1 0.0000
975 ARTHROPATHY 1 0.0000
976 RHEUMATOID ARTHRITIS 2 0.0000
977 MYOCARDIAL INFARCTION 3 0.0000
978 DISEASE PROGRESSION 2 0.0000
979 DEEP VEIN THROMBOSIS 1 0.0000
980 PSORIASIS 2 0.0000
981 RENAL FAILURE 2 0.0000
982 DEVICE MALFUNCTION 1 0.0000
983 CHRONIC KIDNEY DISEASE 1 0.0000
984 DRUG DEPENDENCE 2 0.0000
985 DRUG WITHDRAWAL SYNDROME 1 0.0000
986 DEVICE ISSUE 1 0.0000
987 BREAST CANCER 1 0.0000
988 INJECTION SITE PAIN 2 0.0000